Cargando…
A rationale for considering heart/brain axis control in neuropsychiatric disease
Neuropsychiatric diseases (NPD) represent a significant global disease burden necessitating innovative approaches to pathogenic understanding, biomarker identification and therapeutic strategy. Emerging evidence implicates heart/brain axis malfunction in NPD etiology, particularly via the autonomic...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290621/ https://www.ncbi.nlm.nih.gov/pubmed/36538124 http://dx.doi.org/10.1007/s00335-022-09974-9 |
_version_ | 1785062528983760896 |
---|---|
author | Garrett, Lillian Trümbach, Dietrich Spielmann, Nadine Wurst, Wolfgang Fuchs, Helmut Gailus-Durner, Valerie Hrabě de Angelis, Martin Hölter, Sabine M. |
author_facet | Garrett, Lillian Trümbach, Dietrich Spielmann, Nadine Wurst, Wolfgang Fuchs, Helmut Gailus-Durner, Valerie Hrabě de Angelis, Martin Hölter, Sabine M. |
author_sort | Garrett, Lillian |
collection | PubMed |
description | Neuropsychiatric diseases (NPD) represent a significant global disease burden necessitating innovative approaches to pathogenic understanding, biomarker identification and therapeutic strategy. Emerging evidence implicates heart/brain axis malfunction in NPD etiology, particularly via the autonomic nervous system (ANS) and brain central autonomic network (CAN) interaction. This heart/brain inter-relationship harbors potentially novel NPD diagnosis and treatment avenues. Nevertheless, the lack of multidisciplinary clinical approaches as well as a limited appreciation of molecular underpinnings has stymied progress. Large-scale preclinical multi-systemic functional data can therefore provide supplementary insight into CAN and ANS interaction. We here present an overview of the heart/brain axis in NPD and establish a unique rationale for utilizing a preclinical cardiovascular disease risk gene set to glean insights into heart/brain axis control in NPD. With a top-down approach focusing on genes influencing electrocardiogram ANS function, we combined hierarchical clustering of corresponding regional CAN expression data and functional enrichment analysis to reveal known and novel molecular insights into CAN and NPD. Through ‘support vector machine’ inquiries for classification and literature validation, we further pinpointed the top 32 genes highly expressed in CAN brain structures altering both heart rate/heart rate variability (HRV) and behavior. Our observations underscore the potential of HRV/hyperactivity behavior as endophenotypes for multimodal disease biomarker identification to index aberrant executive brain functioning with relevance for NPD. This work heralds the potential of large-scale preclinical functional genetic data for understanding CAN/ANS control and introduces a stepwise design leveraging preclinical data to unearth novel heart/brain axis control genes in NPD. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00335-022-09974-9. |
format | Online Article Text |
id | pubmed-10290621 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-102906212023-06-26 A rationale for considering heart/brain axis control in neuropsychiatric disease Garrett, Lillian Trümbach, Dietrich Spielmann, Nadine Wurst, Wolfgang Fuchs, Helmut Gailus-Durner, Valerie Hrabě de Angelis, Martin Hölter, Sabine M. Mamm Genome Article Neuropsychiatric diseases (NPD) represent a significant global disease burden necessitating innovative approaches to pathogenic understanding, biomarker identification and therapeutic strategy. Emerging evidence implicates heart/brain axis malfunction in NPD etiology, particularly via the autonomic nervous system (ANS) and brain central autonomic network (CAN) interaction. This heart/brain inter-relationship harbors potentially novel NPD diagnosis and treatment avenues. Nevertheless, the lack of multidisciplinary clinical approaches as well as a limited appreciation of molecular underpinnings has stymied progress. Large-scale preclinical multi-systemic functional data can therefore provide supplementary insight into CAN and ANS interaction. We here present an overview of the heart/brain axis in NPD and establish a unique rationale for utilizing a preclinical cardiovascular disease risk gene set to glean insights into heart/brain axis control in NPD. With a top-down approach focusing on genes influencing electrocardiogram ANS function, we combined hierarchical clustering of corresponding regional CAN expression data and functional enrichment analysis to reveal known and novel molecular insights into CAN and NPD. Through ‘support vector machine’ inquiries for classification and literature validation, we further pinpointed the top 32 genes highly expressed in CAN brain structures altering both heart rate/heart rate variability (HRV) and behavior. Our observations underscore the potential of HRV/hyperactivity behavior as endophenotypes for multimodal disease biomarker identification to index aberrant executive brain functioning with relevance for NPD. This work heralds the potential of large-scale preclinical functional genetic data for understanding CAN/ANS control and introduces a stepwise design leveraging preclinical data to unearth novel heart/brain axis control genes in NPD. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00335-022-09974-9. Springer US 2022-12-20 2023 /pmc/articles/PMC10290621/ /pubmed/36538124 http://dx.doi.org/10.1007/s00335-022-09974-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Garrett, Lillian Trümbach, Dietrich Spielmann, Nadine Wurst, Wolfgang Fuchs, Helmut Gailus-Durner, Valerie Hrabě de Angelis, Martin Hölter, Sabine M. A rationale for considering heart/brain axis control in neuropsychiatric disease |
title | A rationale for considering heart/brain axis control in neuropsychiatric disease |
title_full | A rationale for considering heart/brain axis control in neuropsychiatric disease |
title_fullStr | A rationale for considering heart/brain axis control in neuropsychiatric disease |
title_full_unstemmed | A rationale for considering heart/brain axis control in neuropsychiatric disease |
title_short | A rationale for considering heart/brain axis control in neuropsychiatric disease |
title_sort | rationale for considering heart/brain axis control in neuropsychiatric disease |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290621/ https://www.ncbi.nlm.nih.gov/pubmed/36538124 http://dx.doi.org/10.1007/s00335-022-09974-9 |
work_keys_str_mv | AT garrettlillian arationaleforconsideringheartbrainaxiscontrolinneuropsychiatricdisease AT trumbachdietrich arationaleforconsideringheartbrainaxiscontrolinneuropsychiatricdisease AT spielmannnadine arationaleforconsideringheartbrainaxiscontrolinneuropsychiatricdisease AT wurstwolfgang arationaleforconsideringheartbrainaxiscontrolinneuropsychiatricdisease AT fuchshelmut arationaleforconsideringheartbrainaxiscontrolinneuropsychiatricdisease AT gailusdurnervalerie arationaleforconsideringheartbrainaxiscontrolinneuropsychiatricdisease AT hrabedeangelismartin arationaleforconsideringheartbrainaxiscontrolinneuropsychiatricdisease AT holtersabinem arationaleforconsideringheartbrainaxiscontrolinneuropsychiatricdisease AT garrettlillian rationaleforconsideringheartbrainaxiscontrolinneuropsychiatricdisease AT trumbachdietrich rationaleforconsideringheartbrainaxiscontrolinneuropsychiatricdisease AT spielmannnadine rationaleforconsideringheartbrainaxiscontrolinneuropsychiatricdisease AT wurstwolfgang rationaleforconsideringheartbrainaxiscontrolinneuropsychiatricdisease AT fuchshelmut rationaleforconsideringheartbrainaxiscontrolinneuropsychiatricdisease AT gailusdurnervalerie rationaleforconsideringheartbrainaxiscontrolinneuropsychiatricdisease AT hrabedeangelismartin rationaleforconsideringheartbrainaxiscontrolinneuropsychiatricdisease AT holtersabinem rationaleforconsideringheartbrainaxiscontrolinneuropsychiatricdisease |